← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS TOTOWA · Approved 2008-02-27

Drug application

FDA Application #
ANDA078589
Application type
Abbreviated New Drug Application (Generic)
Brand name
IRINOTECAN HYDROCHLORIDE
Generic name
IRINOTECAN HYDROCHLORIDE
Active ingredients
IRINOTECAN HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
ACTAVIS TOTOWA
Manufacturer
Actavis Pharma, Inc.
First approval
2008-02-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown